Covalon Technologies

Covalon Technologies Current Assets

The Current Assets of Covalon Technologies (COV.V) as of Oct 20, 2026 is 7.40 M CAD. In the previous year, Current Assets was 25.13 M CAD — a change of -70.55% (lower).

Current Assets

7.40 MCAD

YoY

-70.55%

Last updated:

Current Assets of Covalon Technologies is 2025 7.40 M CAD. Current Assets of Covalon Technologies was 2024 25.13 M CAD. It decreases by -70.55% lower compared to the previous year.

The Covalon Technologies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
17.14 M CAD
Jan 1, 2019
22.28 M CAD
Jan 1, 2020
14.85 M CAD
Jan 1, 2021
34.89 M CAD
Jan 1, 2022
25.86 M CAD
Jan 1, 2023
15.13 M CAD
Jan 1, 2024
25.13 M CAD
Jan 1, 2025
7.40 M CAD
The Covalon Technologies Current Assets history
YEARCurrent AssetsYoY
7.40 MCAD-70.55%
25.13 MCAD+66.10%
15.13 MCAD-41.49%
25.86 MCAD-25.89%
34.89 MCAD+134.96%
14.85 MCAD-33.34%
22.28 MCAD+29.97%
17.14 MCAD+75.26%
9.78 MCAD+128.45%
4.28 MCAD-19.06%
5.29 MCAD-1.93%
5.39 MCAD+79.54%
3.00 MCAD-6.48%
3.21 MCAD-47.95%
6.17 MCAD-12.16%
7.02 MCAD-8.91%
7.71 MCAD-41.58%
13.20 MCAD-22.23%
16.97 MCAD+200.79%
5.64 MCAD+291.59%
1.44 MCAD+41.28%
1.02 MCAD+24.39%
820,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Covalon Technologies Stock analysis

What does Covalon Technologies do? Covalon Technologies Ltd. develops and markets patent-protected medical products including advanced wound care solutions, infection prevention technologies, and medical device coatings. The company sells products under its own brand name and also creates medical products for other medical companies through development and license contracts. Its solutions target patients requiring gentle healing with reduced infections and pain, while also serving care providers with specialized medical devices, dressings, and perioperative care systems. The company's portfolio includes antimicrobial skin protection, postoperative incision care, and scar prophylaxis solutions designed for comprehensive patient care from pre-operative to postoperative stages. Covalon's revenue streams come from direct sales of its branded products and licensing agreements with other medical companies for product development. The primary customers are healthcare providers and hospitals seeking advanced wound care and infection prevention solutions. The company focuses on medical device coatings, wound care products, and perioperative care systems as key segments within the medical technology market. Its patented technologies enable both direct product sales and collaborative development partnerships with other medical companies. The company's business model relies on two main revenue channels: selling Covalon-branded medical products directly to healthcare providers and generating income through development and license contracts with other medical companies. Its solutions are designed for patients and made for care providers, emphasizing gentle healing with less infections and pain. The company's product portfolio includes antimicrobial protection for pre-operative skin, postoperative incision care, and scar prophylaxis as part of its perioperative care offerings. Covalon Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Covalon Technologies stock

Current Assets of Covalon Technologies is 7.40 M CAD in 2025.

Current Assets of Covalon Technologies changed from 25.13 M CAD to 7.40 M CAD, representing a -70.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Covalon Technologies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Covalon Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Covalon Technologies

All Key Metrics — Covalon Technologies